4.2 Article

Partially Hydrolyzed Guar Gums Reduce Dietary Fatty Acid and Sterol Absorption in Guinea Pigs Independent of Viscosity

期刊

LIPIDS
卷 47, 期 7, 页码 697-705

出版社

WILEY
DOI: 10.1007/s11745-012-3682-1

关键词

Dietary fiber; Partially hydrolyzed guar gum; Fatty acids; Cholesterol; Bile acids

资金

  1. Torres Quevedo fellowship

向作者/读者索取更多资源

This study investigated the effect of two partially hydrolyzed guar gums (PHGG) on fatty acid and sterol excretion. PHGG were obtained by chemical hydrolysis of guar gum (GG) with H2O:EtOH (1: 1) at 100 degrees C for 1 h (PHGG1) or 2 h (PHGG2). The viscosity of the PHGG in a 1 % (w/v) aqueous solution corresponded to that of a pseudoplastic fluid and was higher for PHGG1 than PHGG2. Guinea pigs (n = 8 per group) were fed high fat diets (17/100 g) that contained 12/100 g of cellulose, PHGG1, or PHGG2 for 4 weeks. Despite the differences in viscosity, the two PHGG exerted similar physiological effects. Compared to the control cellulose group, the body weight gain was lower in animals fed PHGG, although no effect on food consumption was observed. PHGG increased the excretion of fatty acids and neutral sterols, but not bile acids. Consumption of PHGG did not alter the fecal fatty acid profile, while intestinal bioconversion of sterols tended to increase in response to PHGG2. A reduction in the viscosity within the range tested did not correlate with losses in the hypocholesterolemic capacity of PHGG as both were effective in reducing plasma cholesterol. Thus, we conclude that the chemical hydrolysis of guar gum renders the gum suitable for inclusion in food products without significantly altering its beneficial health effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial

J. M. Menchon, J. Espadaler, M. Tuson, J. Saiz-Ruiz, J. Bobes, E. Vieta, E. Alvarez, V. Perez

JOURNAL OF NEURAL TRANSMISSION (2019)

Review Nutrition & Dietetics

The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis

Erola Asto, Iago Mendez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler

NUTRIENTS (2019)

Article Nutrition & Dietetics

Effect of the Degree of Polymerization of Fructans on Ex Vivo Fermented Human Gut Microbiome

Erola Asto, Iago Mendez, Maria Rodriguez-Prado, Jordi Cune, Jordi Espadaler, Andreu Farran-Codina

NUTRIENTS (2019)

Article Pharmacology & Pharmacy

Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies

Silvia Vilches, Miguel Tuson, Eduard Vieta, Enric Alvarez, Jordi Espadaler

PHARMACEUTICS (2019)

Meeting Abstract Biochemistry & Molecular Biology

Derived Postbiotics of a Multi-strain Probiotic Formula Clinically Validated for the Treatment of Irritable Bowel Syndrome

Marta Perez, Erola Asto, Pol Huedo, Cristina Alcantara, David Buj, Jordi Espadaler

FASEB JOURNAL (2020)

Review Immunology

Viral Infections, the Microbiome, and Probiotics

Ashton Harper, Vineetha Vijayakumar, Arthur C. Ouwehand, Jessica ter Haar, David Obis, Jordi Espadaler, Sylvie Binda, Shrilakshmi Desiraju, Richard Day

Summary: Viral infections continue to pose significant global morbidity and mortality, with factors such as climate change, increased mobility of people and goods, and disruptions in the gastrointestinal microbiome all playing a role. Understanding the complex relationship between the microbiome, viral immunity, and host physiology is crucial for developing effective prevention and treatment strategies for viral diseases.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Effects of a Lactobacilli Probiotic on Reducing Duration of URTI and Fever, and Use of URTI-Associated Medicine: A Re-Analysis of a Randomized, Placebo-Controlled Study

Tatiana Altadill, Jordi Espadaler-Mazo, Min-Tze Liong

Summary: The study re-analyzed the effects of Lactoplantibacillus plantarum DR7 probiotic on URTI symptoms and found a significant reduction in the duration of URTI and fever. The recent history of URTI appeared to modulate the efficacy of the probiotic. Additionally, the probiotic group showed a significantly lower average number of months with reported use of URTI-related medication compared to the placebo group.

MICROORGANISMS (2021)

Article Nutrition & Dietetics

A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: Results from a Randomized, Double-Blind, Placebo-Controlled Study

Rafael Guerrero-Bonmatty, Guadalupe Gil-Fernandez, Francisco Jose Rodriguez-Velasco, Jordi Espadaler-Mazo

Summary: This study showed that the combination of 10 mg of monacolin K and L. plantarum strains was effective in managing blood cholesterol, with statistically significant reductions in LDL-C and TC compared to placebo. The intervention was well tolerated with no adverse effects observed.

NUTRIENTS (2021)

Article Genetics & Heredity

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression

Gerard Anmella, Silvia Vilches, Jordi Espadaler-Mazo, Andrea Murru, Isabella Pacchiarotti, Miquel Tuson, Marina Garriga, Eva Sole, Merce Brat, Giovanna Fico, Eduard Vieta

Summary: This study evaluated the impact of individual genes in the response to treatment in bipolar depression, finding that pharmacogenetic variables can predict patient response to medication and tolerability. These predictors could be useful for guiding pharmacological treatment in bipolar disorder, but further clinical studies are needed to confirm these findings.
Article Microbiology

Probiotic Properties of Bifidobacterium longum KABP042 and Pediococcus pentosaceus KABP041 Show Potential to Counteract Functional Gastrointestinal Disorders in an Observational Pilot Trial in Infants

Erola Asto, Pol Huedo, Tatiana Altadill, Meritxell Aguilo Garcia, Maura Sticco, Marta Perez, Jordi Espadaler-Mazo

Summary: This study investigated the probiotic potential of Bifidobacterium longum KABP042 and Pediococcus pentosaceus KABP041 in treating infant FGIDs, confirming their safety and efficacy in in vitro experiments and a pilot study involving infants diagnosed with FGIDs. The strains showed great adhesion capacity to intestinal cells and the ability to antagonize bacterial pathogens alone and in combination, suggesting their potential as a treatment for pediatric FGIDs.

FRONTIERS IN MICROBIOLOGY (2022)

Article Gastroenterology & Hepatology

Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial

Pedro Gutierrez-Castrellon, Tania Gandara-Marti, Ana T. Abreu Y. Abreu, Cesar D. Nieto-Rufino, Eduardo Lopez-Orduna, Irma Jimenez-Escobar, Carlos Jimenez-Gutierrez, Gabriel Lopez-Velazquez, Jordi Espadaler-Mazo

Summary: This study suggests that probiotic supplementation can improve lung homeostasis by interacting with the host's immune system, thereby reducing symptoms and severity of COVID-19 infection.

GUT MICROBES (2022)

Article Gastroenterology & Hepatology

Efficacy of i3.1 Probiotic on Improvement of Lactose Intolerance Symptoms A Randomized, Placebo-controlled Clinical Trial

Ana D. Cano-Contreras, Isidro J. Minero Alfaro, Victor M. Medina Lopez, Mercedes Amieva Balmori, Jose M. Remes Troche, Jordi Espadaler Mazo, Nuria Perez Lopez

Summary: This study assessed the efficacy of probiotic i3.1 in improving symptoms of lactose intolerance. The results showed that the probiotic significantly reduced symptom scores, particularly for abdominal pain and flatulence. However, it did not have a significant effect on the lactose hydrogen breath test results.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)

Article Microbiology

Probiotics diminish the post-operatory pain following mandibular third molar extraction: a randomised double-blind controlled trial (pilot study)

E. Ferres-Amat, J. Espadaler-Mazo, J. L. Calvo-Guirado, J. Mareque-Bueno, A. Salavert, M. Aguilo-Garcia, J. Moreno-Centeno, E. Ferres-Padro

BENEFICIAL MICROBES (2020)

Article Pharmacology & Pharmacy

The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini, Nicola Poloni, Ivano Caselli, Jordi Espadaler, Miquel Tuson, Alessandro Grecchi, Camilla Callegari

PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)

Meeting Abstract Endocrinology & Metabolism

ORAL PROBIOTIC REDUCES PAIN AFTER THIRD MOLAR EXTRACTION PROCEDURE

R. Pons Calabuig, E. Ferres Amat, J. Mareque Bueno, E. Navarro Tapia, E. Asto Sanchez-Lafuente, J. Espadaler Mazo, E. Ferres Padro

ANNALS OF NUTRITION AND METABOLISM (2018)

暂无数据